Skip to main content
. 2022 Jun 2;13:888612. doi: 10.3389/fimmu.2022.888612

Figure 2.

Figure 2

Effects of si-HAPLN1 on RA-FLS activity. Transfection of siHAPLN1 in RA-FLSs did not significantly affect the (A) proliferation but significantly increased (B) apoptosis (magnification: 10×10) and (C, D) migration ability of RA-FLSs. Wound healing (C, magnification: 10×5) and transwell assays (D, magnification: 10×5) were used to measure the migration capacity of FLSs. Recombinant HAPLN1 (50 ng/ml) attenuated the increased migration ability induced by si-HAPLN1 in the transwell assay. *p < 0.05; **p < 0.01; ****p < 0.0001. NC, negative control is control siRNA of si-HAPLN1.